非侵襲的頭蓋内圧モニタリング装置市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、地域別、競合別、2020-2030年

世界の非侵襲的頭蓋内圧（ICP）モニタリング装置市場は、2024年に3億5,123万米ドルと評価され、予測期間中にCAGR 5.43%で成長し、2030年には4億8,306万米ドルに達すると予測されています。

この市場は、定期的な頭蓋内圧モニタリングを必要とする神経疾患や外傷性脳損傷（TBI）の有病率の増加により牽引力を増しています。非侵襲的ICPモニタリング装置は、従来の方法に代わる、より安全で侵襲性の低い選択肢を提供し、感染や患者の不快感などのリスクを大幅に軽減します。救急、外来、クリティカルケア環境での使いやすさが、普及の高まりを支えています。

経頭蓋ドップラー、眼球ベースの技術、画像統合装置など、現在進行中の技術革新により、診断精度と臨床効率が向上しています。ICPデータの解釈における人工知能の役割の高まりは、治療をさらに合理化し、合併症の早期発見をサポートしています。コンパクトな携帯型モデルは、遠隔地やベッドサイドでのモニタリングを可能にし、臨床的有用性を広げています。さらに、小児用やウェアラブル・アプリケーションへの関心も高まっており、非侵襲的ICP装置は現代の神経学的ケアに不可欠なツールとなっています。

主な市場促進要因

外傷性脳損傷（TBI）および神経疾患の発生率の増加

主な市場課題

標準化と臨床検証の欠如

主な市場動向

小児科とクリティカルケアにおける非侵襲的モニタリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の非侵襲的頭蓋内圧モニタリング装置市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 種類別（経頭蓋ドップラー超音波検査、鼓膜変位（TMD）、視神経鞘径、MRI/CT、その他）
  • 用途別（外傷性脳損傷、脳内出血、髄膜炎、くも膜下出血、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の非侵襲的頭蓋内圧モニタリング装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の非侵襲的頭蓋内圧モニタリング装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の非侵襲的頭蓋内圧モニタリング装置市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の非侵襲的頭蓋内圧モニタリング装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの非侵襲的頭蓋内圧モニタリング装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Medtronic plc
• Raumedic AG
• Integra LifeSciences Holdings Corporation
• Spiegelberg GmbH & Co. KG
• Natus Medical Incorporated
• Siemens Healthineers AG
• Sophysa SA
• NeuroWave Systems Inc.
• HeadSense Medical Ltd.
• BrainScope Company, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Non-invasive Intracranial Pressure (ICP) Monitoring Devices Market was valued at USD 351.23 Million in 2024 and is projected to reach USD 483.06 Million by 2030, growing at a CAGR of 5.43% during the forecast period. The market is gaining traction due to the increasing prevalence of neurological conditions and traumatic brain injuries (TBIs) that require regular intracranial pressure monitoring. Non-invasive ICP monitoring devices offer a safer, less intrusive alternative to traditional methods, significantly reducing risks such as infections and patient discomfort. Their ease of use across emergency, outpatient, and critical care environments supports their rising adoption.

Ongoing technological innovations, including devices using transcranial Doppler, ocular-based techniques, and imaging integration, are enhancing diagnostic accuracy and clinical efficiency. The growing role of artificial intelligence in interpreting ICP data is further streamlining care and supporting early detection of complications. Compact, portable models are enabling monitoring in remote and bedside settings, broadening clinical utility. Additionally, interest is expanding in pediatric and wearable applications, positioning non-invasive ICP devices as essential tools in modern neurological care.

Key Market Drivers

Rising Incidence of Traumatic Brain Injuries (TBIs) and Neurological Disorders

The increasing prevalence of TBIs and neurological disorders is a significant factor propelling demand for non-invasive ICP monitoring devices. TBIs, often resulting from falls, accidents, and sports-related injuries, require constant pressure surveillance to avoid secondary brain damage. Non-invasive ICP devices offer a risk-free alternative for such monitoring, ensuring better patient outcomes.

Moreover, neurological disorders such as stroke, epilepsy, and dementia contribute to elevated intracranial pressure and are on the rise globally. For example, dementia affects around 55 million people worldwide, with 10 million new cases each year, while epilepsy impacts approximately 50 million individuals globally. These conditions underscore the clinical importance of safe and accurate ICP monitoring.

Healthcare providers are increasingly integrating non-invasive technologies to improve diagnostic efficiency and patient safety, driving market growth as neurological disease rates continue to climb across all age groups.

Key Market Challenges

Lack of Standardization and Clinical Validation

A key limitation to wider adoption of non-invasive ICP monitoring technologies is the absence of standardized protocols and sufficient clinical validation. Current devices often operate using varied techniques without a unified calibration framework, making it difficult to compare results across different healthcare settings or devices. This variability affects clinician confidence and limits the integration of such tools in high-acuity environments like ICUs.

Furthermore, many non-invasive solutions lack broad-based clinical validation across diverse patient populations, limiting their acceptance among medical professionals. Until these technologies demonstrate consistent reliability and undergo rigorous trials, market penetration may remain constrained, especially in regions with strict regulatory standards and clinical governance frameworks.

Key Market Trends

Non-invasive Monitoring in Pediatrics and Critical Care

The increasing demand for non-invasive ICP monitoring in pediatric and critical care units marks a prominent trend in the market. These patient populations are particularly vulnerable to the risks associated with invasive techniques. In pediatrics, non-invasive methods offer a safer, less traumatic approach for diagnosing conditions linked to elevated ICP.

In critical care, continuous monitoring without the risks of hemorrhage or infection is essential. Non-invasive systems enable round-the-clock surveillance without physically breaching the skull, making them valuable in ICUs and emergency departments. Enhanced device portability and real-time data collection are further enabling widespread clinical use in sensitive care environments.

This trend aligns with the global healthcare focus on minimally invasive, patient-centric technologies, supporting broader integration of non-invasive ICP devices in acute and long-term care protocols.

Key Market Players

• Medtronic plc
• Raumedic AG
• Integra LifeSciences Holdings Corporation
• Spiegelberg GmbH & Co. KG
• Natus Medical Incorporated
• Siemens Healthineers AG
• Sophysa SA
• NeuroWave Systems Inc.
• HeadSense Medical Ltd.
• BrainScope Company, Inc.

Report Scope

In this report, the Global Non-invasive Intracranial Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-invasive Intracranial Pressure Monitoring Devices Market, By Type:

• Transcranial Doppler Ultrasonography
• Tympanic Membrane Displacement (TMD)
• Optic Nerve Sheath Diameter
• MRI/CT
• Others

Non-invasive Intracranial Pressure Monitoring Devices Market, By Application:

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Subarachnoid Hemorrhage
• Others

Non-invasive Intracranial Pressure Monitoring Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-invasive Intracranial Pressure Monitoring Devices Market.

Available Customizations

Global Non-invasive Intracranial Pressure Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Transcranial Doppler Ultrasonography, Tympanic Membrane Displacement (TMD), Optic Nerve Sheath Diameter, MRI/CT, Others)
  • 5.2.2. By Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Non-invasive Intracranial Pressure Monitoring Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Non-invasive Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Medtronic plc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Raumedic AG
• 14.3. Integra LifeSciences Holdings Corporation
• 14.4. Spiegelberg GmbH & Co. KG
• 14.5. Natus Medical Incorporated
• 14.6. Siemens Healthineers AG
• 14.7. Sophysa SA
• 14.8. NeuroWave Systems Inc.
• 14.9. HeadSense Medical Ltd.
• 14.10. BrainScope Company, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer